231 related articles for article (PubMed ID: 6972106)
1. Thymosin administration in autoimmune disorders.
Lavastida MT; Goldstein AL; Daniels JC
Thymus; 1981 Feb; 2(4-5):287-95. PubMed ID: 6972106
[TBL] [Abstract][Full Text] [Related]
2. In vitro effect of thymosin on T-lymphocyte rosette formation in rheumatic diseases.
Moutsopoulos H; Fye KH; Sawada S; Becker MJ; Goldstein A; Talal N
Clin Exp Immunol; 1976 Dec; 26(3):563-73. PubMed ID: 795579
[TBL] [Abstract][Full Text] [Related]
3. Expression of CD5 and CD23 on B cells of patients with rheumatoid arthritis, systemic lupus erythematosus and Sjögren's syndrome. Relationship with disease activity and treatment.
Ebo D; DeClerck LS; Bridts CH; Stevens WJ
In Vivo; 1994; 8(4):577-80. PubMed ID: 7534494
[TBL] [Abstract][Full Text] [Related]
4. [Pulse therapy in the complex treatment of severe forms of Sjögren's syndrome and disease].
Vasil'ev VI; Solov'ev SK; Simonova MV; Safonova TN; Nasonov EL
Ter Arkh; 1986; 58(7):117-22. PubMed ID: 3764727
[TBL] [Abstract][Full Text] [Related]
5. Potential role of thymosin in the treatment of autoimmune diseases.
Goldstein AL; Zatz MM; Low TL; Jacobs R
Ann N Y Acad Sci; 1981; 377():486-95. PubMed ID: 6462093
[No Abstract] [Full Text] [Related]
6. [Thymosin in the treatment of Sjogren's syndrome].
Wen ZX
Zhonghua Kou Qiang Ke Za Zhi; 1986 Jul; 21(4):219-20, 254. PubMed ID: 3471407
[No Abstract] [Full Text] [Related]
7. Tolerance and short term efficacy of rituximab in 43 patients with systemic autoimmune diseases.
Gottenberg JE; Guillevin L; Lambotte O; Combe B; Allanore Y; Cantagrel A; Larroche C; Soubrier M; Bouillet L; Dougados M; Fain O; Farge D; Kyndt X; Lortholary O; Masson C; Moura B; Remy P; Thomas T; Wendling D; Anaya JM; Sibilia J; Mariette X;
Ann Rheum Dis; 2005 Jun; 64(6):913-20. PubMed ID: 15550531
[TBL] [Abstract][Full Text] [Related]
8. Practical use of immunosuppressive drugs in autoimmune rheumatic diseases.
De Jesus A; Talal N
Crit Care Med; 1990 Feb; 18(2 Suppl):S132-7. PubMed ID: 2298028
[TBL] [Abstract][Full Text] [Related]
9. Immunoblastic sarcoma in patients with systemic lupus erythematosus-like disorders.
Stevanovic G; Cramer AD; Taylor CR; Lukes RJ
Arch Pathol Lab Med; 1983 Nov; 107(11):589-92. PubMed ID: 6226252
[TBL] [Abstract][Full Text] [Related]
10. A syndrome of multiple immune autoreactivity. A breakdown in immune regulation.
Diaz LA; Glamb RW; Silva J
Arch Dermatol; 1980 Jan; 116(1):77-9. PubMed ID: 6986118
[TBL] [Abstract][Full Text] [Related]
11. [Sjögren syndrome. Analysis of 43 patients].
Villar Ortiz J; Palomino-Nicas J; Conde García J; Piedra Priego J; Manso García F; Lapetra Peralta J
Rev Clin Esp; 1985 May; 176(9):442-7. PubMed ID: 4023331
[No Abstract] [Full Text] [Related]
12. Relationship of Sjögren's syndrome to other connective tissue and autoimmune disorders.
Theander E; Jacobsson LT
Rheum Dis Clin North Am; 2008 Nov; 34(4):935-47, viii-ix. PubMed ID: 18984413
[TBL] [Abstract][Full Text] [Related]
13. Autoimmune and chronic inflammatory disorders and risk of non-Hodgkin lymphoma by subtype.
Smedby KE; Hjalgrim H; Askling J; Chang ET; Gregersen H; Porwit-MacDonald A; Sundström C; Akerman M; Melbye M; Glimelius B; Adami HO
J Natl Cancer Inst; 2006 Jan; 98(1):51-60. PubMed ID: 16391371
[TBL] [Abstract][Full Text] [Related]
14. Elevated levels of soluble CD40 ligand (sCD40L) in serum of patients with systemic autoimmune diseases.
Goules A; Tzioufas AG; Manousakis MN; Kirou KA; Crow MK; Routsias JG
J Autoimmun; 2006 May; 26(3):165-71. PubMed ID: 16621447
[TBL] [Abstract][Full Text] [Related]
15. [Association of systemic lupus erythematosus and Sjögren's syndrome].
Szántó A; Kiss E; Sas A; Szegedi G; Zeher M
Orv Hetil; 2005 Dec; 146(50):2533-8. PubMed ID: 16440498
[TBL] [Abstract][Full Text] [Related]
16. The dual association between lymphoma and autoimmunity.
Ehrenfeld M; Abu-Shakra M; Buskila D; Shoenfeld Y
Blood Cells Mol Dis; 2001; 27(4):750-6. PubMed ID: 11778659
[TBL] [Abstract][Full Text] [Related]
17. Post-mortem prevalence of lymphocytic infiltration of the lacrymal gland: a comparative study in autoimmune and non-autoimmune diseases.
Nasu M; Matsubara O; Yamamoto H
J Pathol; 1984 May; 143(1):11-5. PubMed ID: 6737113
[TBL] [Abstract][Full Text] [Related]
18. [Sjögren's syndrome and polyarthritis].
Saudan Y
Schweiz Med Wochenschr; 1967 Nov; 97(47):1576-81. PubMed ID: 5596886
[No Abstract] [Full Text] [Related]
19. Immunologic evaluation of rheumatoid arthritis and therapy with levamisole.
Verhaegen H; de Cree J; de Cock W; Schuermans Y; Engels M; Sonck W
Biomedicine; 1977 Jul; 26(4):283-91. PubMed ID: 922113
[TBL] [Abstract][Full Text] [Related]
20. Comparison of antinuclear antibody and other immunohematological profiles among primary Sjögren's syndrome, secondary Sjögren's syndrome associated with rheumatoid arthritis or systemic lupus erythematosus, and corresponding systemic disease.
Ichikawa Y; Takaya M; Shimizu H; Uchiyama M; Moriuchi J; Morita K; Hoshina Y; Horiki T
Tokai J Exp Clin Med; 1993 Dec; 18(3-6):133-8. PubMed ID: 7701526
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
